 Brainstorm Cell Therapeutics, Inc. is a biotechnology company developing best-in-class autologous cell therapies for treating neurodegenerative diseases including ALS, PMS, Alzheimers, and others. Brainstorms modified mesenchymal stem cells are being tested in one ongoing Phase 2 trial for PMS promising top-line data and one soon-to-be-initiated Phase 2 trial for Alzheimers. 